| Wings for Life World Run doesn’t just raise money – it supports selecting, funding, and accelerating the most promising spinal cord research in the world. |
| In 2003, two-time motocross world champion Heinz Kinigadner’s son Hannes became tetraplegic after an accident. When he and Dietrich Mateschitz tried to fund spinal cord research, they found a field lacking the funding and support needed to drive progress: too rare for pharma and too complex for most government priorities. So they set out to change that.
Founded in 2004, Wings for Life is not only a non-profit foundation but also an incubator dedicated to advancing spinal cord research, selecting the most promising science from more than 250 applications each year. Since then, it has funded 344 projects, with 72 currently active across four continents. Through its Accelerated Translational Program, the only program of its kind dedicated exclusively to spinal cord injury, the foundation helps accelerate discoveries from the laboratory towards clinical trials. A partnership with Microsoft’s AI For Good Lab now brings artificial intelligence to bear on the field’s most stubborn data problem — small patient populations, fragmented datasets, and recovery timescales too long for conventional analysis. One of the foundation’s biggest fundraising sources is the Wings for Life World Run, a simultaneous global event on 10 May 2026, where every single participant is a direct research funder. Because all administrative costs are covered independently of donations, 100% of every entry fee goes directly to spinal cord research. No overhead. No deduction. In 2025, 310,719 participants raised €8.6 million in a single day. The foundation’s work has already produced results once considered impossible. A study co-funded by Wings for Life investigating a drug candidate showed a three-fold increase in motor connectivity to key hand muscles in patients whose neurological recovery had been considered complete, up to ten years after injury. A nerve stimulation technique, published in Nature, improved arm and hand strength in chronic spinal cord injury, where therapy alone produced no benefit at all. The question is no longer whether spinal cord injury will be treatable, but when. Key Facts at a Glance
How the Research Incubator Works Wings for Life receives more than 250 applications annually from scientists across 30 countries, evaluated by a network of 737 independent expert reviewers and an internationally renowned Scientific Advisory Board. Only the most promising projects receive funding, held to defined milestones and required to publish all results, positive and negative. Currently, 72 ongoing research projects across 15 countries span the full pipeline: 42 percent basic research, 40 percent preclinical, 18 percent clinical. For the most promising discoveries, the Accelerated Translational Program (ATP) goes beyond funding, providing regulatory guidance, clinical trial design expertise, and access to international clinical networks. It is the only programme of its kind dedicated exclusively to spinal cord injury, bridging the gap that kills most viable science before it ever reaches a patient. „Spinal cord injuries are incredibly complex, and no one yet knows which approach will ultimately succeed. That’s why we back the best science across all promising avenues,” says Verena May, Executive Director Research Portfolio at Wings for Life. „We’ll likely need a toolbox of solutions, so each individual can receive the treatment that fits their specific situation.” „We don’t just fund science, we actively shape the path from discovery to treatment,” says Anita Gerhardter, Executive Chair of the Board at Wings for Life. AI Partnership with Microsoft and the Open Data Foundation Wings for Life and Microsoft’s AI For Good Lab have launched the foundation’s first dedicated AI funding programme, targeting spinal cord injury research’s most persistent structural problem: small patient populations, heterogeneous injury patterns, and historically fragmented data. These are precisely the conditions where AI-driven pattern recognition outperforms conventional analysis, identifying treatment response patterns, modelling individual recovery trajectories, and flagging candidate compounds from existing drug libraries. Separately, Wings for Life also co-funds the Open Data Commons for Spinal Cord Injury (ODC-SCI), developed by Prof. Adam Ferguson (University of California, San Francisco) and Prof. Karim Fouad (University of Alberta, Canada). The platform makes preclinical and clinical data freely discoverable worldwide under FAIR principles – Findable, Accessible, Interoperable, Reusable – and encourages funded researchers to make their results available there, including negative findings. The initiative is separate from the foundation’s AI partnership with Microsoft. „If we share data, we can achieve much faster progress,” says Karim Fouad. „By combining datasets with modern analysis tools, they can provide completely new insights,” adds Adam Ferguson. „AI offers new ways to spot patterns previously hidden, even with small and diverse patient groups,” says Verena May. „This could accelerate the development of new therapies significantly.” NVG-291 – From Funded Research to Clinical Breakthrough The clearest proof the model works: NVG-291, a first-in-class therapeutic peptide developed by NervGen Pharma Corp., was co-financed by Wings for Life with US$2.56 million through the Accelerated Translational Program. After spinal cord injury, scar tissue blocks nerve regrowth. NVG-291 blocks the scar’s docking site rather than attacking it directly — making tissue more permeable and supporting nerve regeneration. In the Phase 1b/2a CONNECT SCI Study, patients injured one to ten years ago who received NVG-291 achieved approximately three times stronger motor signal transmission to a key hand muscle versus placebo. Expanded data published in November 2025 showed a 3.7-fold greater improvement in quantitative hand prehension versus placebo at Week 16 – with functional gains continuing to strengthen after the treatment period ended. The drug was well-tolerated with no serious side effects. Crucially, these improvements occurred in people whose neurological recovery was considered complete. To date, there is no approved drug therapy enabling functional recovery after spinal cord injury. NVG-291 could become the first. „There is still no cure and no approved treatment. With our NervGen study, we want to close exactly this gap,” says Prof. Monica Perez, study leader at the Shirley Ryan AbilityLab in Chicago. Vagus Nerve Stimulation Improves Arm and Hand Function A second clinical milestone comes from neuroscientist Professor Michael Kilgard and his team at the Texas Biomedical Device Center, University of Texas at Dallas, whose results were published in the journal Nature (doi: 10.1038/s41586-025-09028-5). The randomised, double-blind, sham-controlled study enrolled nineteen people with chronic incomplete cervical spinal cord injury. Over twelve weeks, participants completed an intensive rehabilitation programme combining progressive, individualised physical therapy with gamified video-based exercises using force and motion sensors to target specific upper-limb movements. One group also received closed-loop vagus nerve stimulation — electrical pulses delivered via a miniaturised implant in the neck, triggered in real time each time a participant successfully completed a movement. This closed-loop approach targets neuroplasticity: the ability of the nervous system to reorganise and form new connections in response to experience. Participants achieved significant improvements in arm and hand strength and the ability to perform functional upper-limb tasks. Therapy alone produced no improvement in the control group — the gains observed occurred exclusively in the stimulation arm. The procedure proved safe across 3.7 million stimulations with zero complications. „Therapy alone for spinal cord injury didn’t help our participants at all,” says Kilgard. „It is truly groundbreaking that we’re creating a gain where there otherwise would be none.” The next step on that path is potential FDA approval. A Unique Event Format: No Finish Line, One Global Start All participants – runners, walkers, and wheelchair users — start simultaneously at 11:00 AM UTC across 191 nations. There is no finish line. Instead, 30 minutes after the start, a Catcher Car begins at 14 km/h, accelerating in stages every 30 minutes until it passes every participant. Results are measured in distance, not time. The format is open to all ages and fitness levels — and uniquely, no participant knows in advance how far they will go. Someone who sets out to run 10 kilometres may find themselves completing a marathon. The Catcher Car is the only finish line that moves, which means every distance – from first-time runners to elite athletes — is a legitimate result on the same course, at the same moment, worldwide. The records reflect the format’s range. In 2025, Jo Fukuda (Japan) ran 71.67 km in Fukuoka – a new men’s world record and his third title. Esther Pfeiffer (Germany) won the women’s title with 59.03 km in Munich. The all-time distance record belongs to wheelchair athlete Aron Anderson (Sweden): 92.14 km, Dubai, 2017. „One day each year, the whole world moves for those who can’t — all together at the same time,” says Anita Gerhardter, Executive Chair of the Board at Wings for Life. „Every step, every kilometre, every donation brings us closer to a cure.” 13th Edition: 10 May 2026 The 2026 Wings for Life World Run takes place on 10 May 2026, with flagship runs in Zug, Munich, Ljubljana, Vienna, Zadar, Poznan, and Breda, alongside 572 community-led App Run Events across 73 countries. App-based participation is also available worldwide. The event is broadcast live on Red Bull TV. Participants can register at wingsforlifeworldrun.com. The State of Spinal Cord Injury Research Each year, between 250,000 and 500,000 people worldwide suffer a spinal cord injury — most often in a moment of ordinary life. The leading causes are traffic accidents (50 percent) and falls (24 percent). When the spinal cord is damaged, signals between the brain and the body are disrupted. The result is paraplegia — paralysis of the legs and lower body — in approximately 53 percent of cases, and tetraplegia — paralysis of all four limbs — in approximately 47 percent. Beyond movement, vital functions including breathing, blood pressure, bladder and bowel control, and sexual function are also affected. There is currently no cure. That last sentence is changing. „The question is no longer whether spinal cord injury will be treatable, but when,” says Verena May, Executive Director, Research Portfolio at Wings for Life. „Multiple therapies are now in clinical trials, some already showing positive results. So many more approaches are fuelling the preclinical pipeline.” Register for the Wings for Life World Run on May 10, 2026, HERE. Keywords & Entity Tags Primary Entities: Wings for Life World Run; Wings for Life Foundation; NVG-291; NervGen Pharma; CONNECT SCI Study; Accelerated Translational Program (ATP); Open Data Commons for Spinal Cord Injury (ODC-SCI); Catcher Car; Microsoft AI For Good Lab Topics: spinal cord injury; spinal cord research; spinal cord injury cure; neuroplasticity; nerve regeneration; glial scar; vagus nerve stimulation; electrical stimulation; stem cell therapy; magnetic nanotechnology; rehabilitation; clinical trial; Phase 1b/2a; charity running event; inclusive running event; wheelchair running event; AI in medicine; open data; FAIR principles; spinal cord injury treatment 2025 2026 Event Terms: Wings for Life World Run 2026; Catcher Car race; no finish line run; largest simultaneous running event; global charity run; 100 percent donations to research; flagship run; app run About Wings for Life Worldwide, millions of people are dependent on a wheelchair after having sustained a spinal cord injury, most often as the result of a traffic accident or a fall. Wings for Life is a not-for-profit spinal cord research foundation with the single mission to find a cure for spinal cord injury. Founded in 2004 by two-time motocross world champion Heinz Kinigadner and Dietrich Mateschitz, the foundation was established after Kinigadner’s son Hannes became tetraplegic following a tragic accident in 2003. Since 2004, Wings for Life has funded 344 research projects and clinical trials worldwide, with funded scientists working at renowned institutions including Charité Berlin, Harvard Medical School, and the University of Cambridge. All administrative costs of the foundation are covered independently of donations, ensuring 100% of all donations go directly to spinal cord research. For more information: wingsforlife.com About the Wings for Life World Run Once a year, the Wings for Life World Run takes place around the globe. All participants start at the same time worldwide and run either individually with the Wings for Life World Run App or together at flagship runs. The event is open to all ages and fitness levels — runners, walkers, and wheelchair users alike. There is no traditional finish line; instead, a Catcher Car starts 30 minutes after the race begins, accelerating in stages until it passes every participant. Results are measured in distance, not time. In the editions completed to date, a total of 1,870,253 registered participants from 191 nationalities ran, walked, and rolled on all seven continents and together raised a total of €60.53 million to find a cure for spinal cord injury. 100% of entry fees and donations go directly to spinal cord research. For more information: wingsforlifeworldrun.com |
